As shown for colorectal cancer where p53 negative cells were less responsive to anti-angiogenic treatment than wild-type p53 cells [29], alteration of p53 signaling may also be an explanation for the low response rate in ccRCC. Here, TP53 is linked to nonpapillary renal cell carcinoma.